Title : Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

Pub. Date : 2017 Jul

PMID : 28392500






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Compared with placebo, rosuvastatin decreased LDL cholesterol and apoB-100 levels in TRL, lbLDL, and sdLDL by significantly increasing the fractional catabolic rate of apoB-100 (TRL, +45%; lbLDL, +131%; and sdLDL, +97%), without a change in production. Rosuvastatin Calcium apolipoprotein B Homo sapiens
2 Compared with placebo, rosuvastatin decreased LDL cholesterol and apoB-100 levels in TRL, lbLDL, and sdLDL by significantly increasing the fractional catabolic rate of apoB-100 (TRL, +45%; lbLDL, +131%; and sdLDL, +97%), without a change in production. Rosuvastatin Calcium apolipoprotein B Homo sapiens
3 Rosuvastatin enhances the catabolism of apoB-100 in both lbLDL and sdLDL. Rosuvastatin Calcium apolipoprotein B Homo sapiens